These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31652854)

  • 1. Epigenetic Activation of
    Donovan MG; Selmin OI; Doetschman TC; Romagnolo DF
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein Prevents
    Romagnolo DF; Donovan MG; Papoutsis AJ; Doetschman TC; Selmin OI
    Curr Dev Nutr; 2017 Jun; 1(6):e000562. PubMed ID: 29955703
    [No Abstract]   [Full Text] [Related]  

  • 3. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol.
    Papoutsis AJ; Selmin OI; Borg JL; Romagnolo DF
    Mol Carcinog; 2015 Apr; 54(4):261-9. PubMed ID: 24136580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells.
    Papoutsis AJ; Borg JL; Selmin OI; Romagnolo DF
    J Nutr Biochem; 2012 Oct; 23(10):1324-32. PubMed ID: 22197621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.
    Papoutsis AJ; Lamore SD; Wondrak GT; Selmin OI; Romagnolo DF
    J Nutr; 2010 Sep; 140(9):1607-14. PubMed ID: 20631324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.
    Selmin OI; Donovan MG; Skovan B; Paine-Murieta GD; Romagnolo DF
    Int J Oncol; 2019 Mar; 54(3):869-878. PubMed ID: 30664189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
    Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
    Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
    Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
    J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
    Hockings JK; Thorne PA; Kemp MQ; Morgan SS; Selmin O; Romagnolo DF
    Cancer Res; 2006 Feb; 66(4):2224-32. PubMed ID: 16489025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of AR antagonist combined with PARP1 inhibitor on sporadic triple-negative breast cancer bearing AR expression and methylation-mediated BRCA1 dysfunction.
    Sang M; Meng L; Ma C; Liu S; Sang M; Chang S; Liu F; Lian Y; Geng C
    Biomed Pharmacother; 2019 Mar; 111():169-177. PubMed ID: 30580238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
    Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
    PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
    Arif T; Anwar N
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.
    de Assis S; Warri A; Benitez C; Helferich W; Hilakivi-Clarke L
    Cancer Prev Res (Phila); 2011 Sep; 4(9):1436-48. PubMed ID: 21680703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms.
    Sharma M; Arora I; Chen M; Wu H; Crowley MR; Tollefsbol TO; Li Y
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
    Safe S; Wormke M; Samudio I
    J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.